Why Digital Pathology’s Ecosystem Won’t Support AI Startups

While the total digital pathology AI industry is predicted to grow significantly, competition among players will likely be difficult due to consolidation and cannibalization. How can investors determine where their funds are the safest. Digital pathology (DP) has received a lot of media attention lately, so much so that it might be difficult to recall a time when this business was consistently "lagging" behind other digital healthcare industries. Even while growth has now firmly entered its "log" phase, there are still a few things investors and other stakeholders should keep in mind. A lab has to have access to and be using a DP scanner in order to use DP AI.